Small Molecules
5 April 2018
Conatus Pharmaceuticals Announces Top-line Results from Phase 2b POLT-HCV-SVR Clinical Trial3 April 2018
Rigel Announces Topline Data from Proof-of-Concept Phase 2 Study of Fostamatinib in IgA Nephropathy29 March 2018
RXC004 Clinical Trial Update29 March 2018
Commencement Of Phase II Clinical Study Of GDC-008428 March 2018
Combioxin Announces Completion of CAL02 FIM Trial in Patients with Severe Pneumococcal Pneumonia28 March 2018
Urovant Sciences Initiates Phase 3 Clinical Program for Vibegron in Patients with Overactive BladderNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports